NOTICE OF EXTRAORDINARY GENERAL MEETING IN BIOTAGE AB

NOTICE OF EXTRAORDINARY GENERAL MEETING IN BIOTAGE AB

Shareholders in Biotage AB are hereby invited to attend the Extraordinary
General Meeting, to be held on Friday, November 21, 2008, at 10.00 a.m., at the
head office of Biotage AB, Kungsgatan 76 in Uppsala, Sweden.

Notice etc. 
Shareholders who wish to participate in the Extraordinary General Meeting must 
a) be recorded as a shareholder in the share register maintained by VPC on
Friday, November 14, 2008, and 
b) notify the company of their intention to participate in the Extraordinary
General Meeting, no later than Monday, November 17, 2008, at 4.00 p.m. 
Notice of participation in the Extraordinary General Meeting may be made to the
company by mail to the address Kungsgatan 76, SE-753 18 Uppsala, Sweden, by fax
+ 46-18-591922, or by e-mail: deltagare@eu.biotage.com. The notification should
include the following information: name, social security number/corporate
registration number, address, telephone number, shareholdings and number of
accompanying assistants (maximum two).
Shareholders participating through a representative must provide a proxy for the
representative. If the proxy is issued by a legal entity, a certified copy of
the registration certificate for the legal entity must be enclosed. The proxy
may not be older than one year. The proxy in the original and, where applicable,
the registration certificate should be sent in due time prior to the
Extraordinary General Meeting, to Biotage AB at the address Kungsgatan 76, 753
18 Uppsala, Sweden. A proxy form is available at www.biotage.com/proxy.
To be entitled to participate in the Extraordinary General Meeting, shareholders
whose shares are nominee registered must temporarily have the shares
owner-registered with VPC. Shareholders who wish to make such re-registration
must notify their nominee thereof. The re-registration must be made no later
than on Friday, November 14, 2008, and the shareholders should in due time
before such date notify the nominee thereof.

Number of shares and votes
In the company there are in total 88,486,320 shares with one vote each.

Proposed Agenda 
1. Opening of the Extraordinary General Meeting and election of the Chairman. 
2. Preparation and approval of the voting list. 
3. Approval of the agenda. 
4. Election of two persons to approve the minutes. 
5. Determination whether the Extraordinary General Meeting has been duly
convened. 
6. Resolution on reduction of statutory reserve. 
7. Closing of the Extraordinary General Meeting. 

Item 6 - Proposal for resolution on reduction of statutory reserve 
With the objective to increase the company's financial flexibility, Biotage's
Board of Directors proposes that the company's statutory reserve shall be
reduced with an amount of SEK 842.180.000 by means of transfer of the aforesaid
amount to a reserve to be used in accordance with resolution/s adopted at
forthcoming General Meetings. The statutory reserve will be entirely dissolved
following the execution of the said reduction. Approval by the Swedish Companies
Registration Office (Sw. Bolagsverket), or the general court (Sw. allmän
domstol) in case of a dispute, is required to effectuate the proposed reduction
of statutory reserve. 

Uppsala in November 2008 
Biotage AB (publ) 
The Board of Directors

Contact
Torben Jörgensen, President and CEO	
Tel: +46 707 49 05 84, torben.jorgensen@eu.biotage.com

About Biotage 
Biotage is a global company active in life science research with strong
technologies, a broad range of operations and a long-term view of the market.
The company offers solutions, knowledge and experience in the area of medicinal
chemistry. In 2005 business and products from the company Argonaut were
acquired, further strengthening the product range in medicinal chemistry. The
customers include the worlds top 30 pharma companies, the worlds top 20 biotech
companies, and leading academic institutes. The company is headquartered in
Uppsala and has subsidiaries in the U.S., Japan, UK, Germany and several other
European countries. Biotage has 300 employees and had sales of SEK 496m in 2007.
Biotage is listed on the OMX Nordic stock exchange. Website: www.biotage.com